AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2011
Jan 31, 2011
29745_dirs_2011-01-31_ac7d6257-d3dc-4ba1-a3dc-b63a0eecba56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-12-31
Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-22 | Common Stock | G | 330 | $0.00 | Disposed | 75410 | Direct |
| 2010-04-28 | Common Stock | G | 175 | $0.00 | Disposed | 75235 | Direct |
| 2010-05-03 | Common Stock | G | 145 | $0.00 | Disposed | 75090 | Direct |
| 2010-06-21 | Common Stock | G | 1160 | $0.00 | Disposed | 73930 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6082 | Indirect |
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29